Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-24T03:44:51.264Z Has data issue: false hasContentIssue false

Convener's Foreword

Published online by Cambridge University Press:  07 January 2005

Barry Reisberg
Affiliation:
Pharmacy and Therapeutics Committee, International Psychogeriatric Association and Meeting Convener

Extract

This issue is a product of a special meeting ofthe International Psychogeriatric Association (IPA). The meeting, entitled “Outcome Methodologies for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer's Disease,” was held under the auspices of the IPA's Pharmacy and Therapeutics Comniittee on July 26, 1994, at the New York University Medical Center in New York City. The purpose of the meeting was to bring together leading scientists, clinicians, and regulatory personnel to address issues surrounding assessment of treatment efficacy in Alzheimer's disease (AD).

Type
Other
Copyright
© 1996 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)